Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404.
Prados MD, Scott C, Sandler H, Buckner JC, Phillips T, Schultz C, Urtasun R, Davis R, Gutin P, Cascino TL, Greenberg HS, Curran WJ Jr. Prados MD, et al. Among authors: urtasun r. Int J Radiat Oncol Biol Phys. 1999 Dec 1;45(5):1109-15. doi: 10.1016/s0360-3016(99)00265-5. Int J Radiat Oncol Biol Phys. 1999. PMID: 10613302 Clinical Trial.
Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404.
Prados MD, Seiferheld W, Sandler HM, Buckner JC, Phillips T, Schultz C, Urtasun R, Davis R, Gutin P, Cascino TL, Greenberg HS, Curran WJ Jr. Prados MD, et al. Among authors: urtasun r. Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1147-52. doi: 10.1016/j.ijrobp.2003.08.024. Int J Radiat Oncol Biol Phys. 2004. PMID: 15001257 Clinical Trial.
Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06.
Scott CB, Scarantino C, Urtasun R, Movsas B, Jones CU, Simpson JR, Fischbach AJ, Curran WJ Jr. Scott CB, et al. Among authors: urtasun r. Int J Radiat Oncol Biol Phys. 1998 Jan 1;40(1):51-5. doi: 10.1016/s0360-3016(97)00485-9. Int J Radiat Oncol Biol Phys. 1998. PMID: 9422557 Clinical Trial.
NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients.
Ali AN, Zhang P, Yung WKA, Chen Y, Movsas B, Urtasun RC, Jones CU, Choi KN, Michalski JM, Fischbach AJ, Markoe AM, Schultz CJ, Penas-Prado M, Garg MK, Hartford AC, Kim HE, Won M, Curran WJ Jr. Ali AN, et al. J Neurooncol. 2018 Mar;137(1):39-47. doi: 10.1007/s11060-017-2558-x. Epub 2018 Feb 5. J Neurooncol. 2018. PMID: 29404979 Free PMC article. Clinical Trial.
131 results